Concerns over weakening demand for Indian pharmaceutical (pharma) drugs in the US — their largest export market — have weighed heavily on investor sentiment this year. Photograph: Amit......
The market regulator’s newly proposed selection criteria for the over Rs 400-trillion-a-day futures and options (F&O) market could pave the way for the entry of popular stocks such as Life......
Abbott India Ltd has registered a 88.64 per cent rise in net profit at Rs 19.43 crore (Rs 194.3 million) for the first quarter ended February 29 compared to Rs 10.3 crore (Rs 103 million) reported......
Abbott India Ltd has posted a net profit of Rs 144.15 million for the quarter ended November 30, 2002 as compared to a net profit of Rs 77.50 million for the quarter ended November 30, 2001. Total......
Abbott India outperformed the Indian pharmaceutical market (IPM) with a year-on-year (YoY) growth of 23 per cent in February. Photograph: Shailesh Andrade/Reuters The domestic market grew at a......